🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Rib fractures cause a significant amount of pain and are associated with an...
Status
Enrolling By Invitation
Location
University of California, Irvine
Start Date
2025-11-13
Trial ID
NCT07145346
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics (PK), safety,...
Status
Completed
Location
ICON Salt Lake City
Start Date
2023-05-03
Trial ID
NCT05851157
Treatments Being Tested
This prospective, single-arm feasibility study will evaluate postoperative ...
Status
Completed
Location
Mayo Clinic in Florida
Start Date
2025-10-20
Trial ID
NCT07257133
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of suzetri...
Status
Completed
Location
Shoals Medical Trials Inc.
Start Date
2022-10-03
Trial ID
NCT05553366
Treatments Being Tested
The purpose of this study is to evaluate the safety and effectiveness of VX...
Status
Completed
Location
Anaheim Clinical Trials
Start Date
2023-01-09
Trial ID
NCT05661734
Treatments Being Tested
The purpose of the study is to evaluate the effects of clinical and high cl...
Status
Completed
Location
ICON Lenexa
Start Date
2023-04-12
Trial ID
NCT05818852
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics and safety of...
Status
Completed
Location
Division of Clinical Pharmacology, University of Miami
Start Date
2022-10-14
Trial ID
NCT05560464
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics of midazolam ...
Status
Completed
Location
Baltimore - Early Phase Clinical Unit
Start Date
2022-09-22
Trial ID
NCT05541471
The purpose of this study is to evaluate the efficacy and safety of VX-548 ...
Status
Completed
Location
Arizona Research Center
Start Date
2021-08-30
Trial ID
NCT05034952
Treatments Being Tested
Suzetrigine is a selective NaV1.8 inhibitor that provides peripheral analge...
Status
Not Yet Recruiting
Location
University of California, Los Angeles (UCLA)
Start Date
2026-07-01
Trial ID
NCT07600697
Treatments Being Tested